Sphingolipids Market is anticipated to reach US$ 991.8 Million by end of 2032, at a CAGR of 5.1%

In 2022, the sphingolipids market size worldwide was valued at around US$ 601.3 Million. It is anticipated that the global market will grow at a compound annual growth rate (CAGR) of 5.1% and reach an expected value of approximately US$ 991.8 Million by the end of 2032.

Sphingolipids are a type of lipid that contains sphingoid bases as their backbone, including sphingosine. They are found in various biological processes such as tissue development, cell identification and adhesion, and serving as toxin receptors. They also play a crucial role in the central nervous system.

Get Full PDF Sample Copy of Latest Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15713

The expanding market for sphingolipid products is driven by the rapid customization of sphingolipid components/formulations and the increasing prevalence of cardiovascular diseases worldwide, especially in the elderly population. The demand for natural, synthetic, and semi-synthetic sphingolipids and monomers is expected to increase during the forecast period due to their use in creating various pharmaceutical formulations.

However, the sphingolipids market is not reaching its full potential due to unexplored benefits in the healthcare sector and the possible side effects of inappropriately consuming sphingolipids. Companies are introducing novel components/formulations with minimal side effects and reasonable costs to improve adoption and consumption of pharmaceutical sphingolipids. This, coupled with rising product launches and approvals, is expected to contribute to market growth in the forecast period.

North America is expected to hold the largest share of the sphingolipids market due to the increasing demand for these compounds in the pharmaceutical industry. The presence of a well-established healthcare sector and increasing investment in research and development activities are expected to drive market growth in this region.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you@ https://www.futuremarketinsights.com/ask-question/rep-gb-15713

Key Takeaways from Market Study

• Sphingomyelin is the leading segment as a product and holds approximately 29.0% market share in 2021, due to its anti-cancer, bacteriostatic, and cholesterol-lowering characteristics.
• Synthetic sphingolipids are the leading segment by source, and held about 38.4% market share in 2021, owing to their potential as therapeutic prospects for treating a range of medical problems.
• Conventional lipid-based drug delivery systems (LBDDS) is the leading segment in terms of application holding about 61.9% of the market share, as compared to traditional tablets or powder-filled capsules, as they can improve bioavailability and reduce dissolving rate-limited absorption because of their pharmacological composition in a solubilized condition.
• Semi-solid form of sphingolipids is the leading form as of 2021, withholding about 61.9% of the global market share, owing to the property of reduced adverse side effects when a high drug load is applied to the area where the medication is actually required.
• Pharmaceutical companies are the leading end users of the global market as of 2021, withholding about 35.5% of the market share, because of increased outsourcing, innovative modalities, and creative patient outreach tactics.
• By region, North America is leading in the global sphingolipids market and is expected to continue to do so with a projected CAGR of 5.4% during the forecasted years.

“Rising initiatives to promote health benefits of sphingolipids products, as well as the increasing ongoing research and development in modifying novel sphingolipids formulations is set to propel the market of sphingolipids across the globe,” says an analyst of Future Market Insights.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/15713

Market Competition

Key players in the Sphingolipids Market are:

Merck KGaA, CordenPharma International, Lipoid GmbH, LARODAN AB, Croda International Plc., Biosynth, Santa Cruz Biotechnology, Inc., Creative Enzymes, CD Bioparticles, Cayman Chemical Company, and Others

Companies are actively working to increase their market share in this industry by forming strategic agreements to diversify their respective service offerings and sphingolipid production capacities.

• In January 2022, Pfizer and Acuitas Therapeutics reached an agreement on Lipid Nanoparticle Delivery System for mRNA vaccines and therapeutics.
• June 2022: To support customers’ scientific research, CD Bioparticles, enlarged its lipid system portfolio and introduced a number of Sphingolipids products. With the addition of Phosphosphingolipids, Ceramides, Sphingolipid Metabolism, Sphingosines, Glycosphingolipids, Phytosphingosine, and Sphingomyelin, researchers now have more options to choose from and employ in lipid system applications.

Key Segments Covered In Sphingolipids Industry Research

By Product:

• Ceramide
• Sphingomyelin
• Glucosylceramide (GlcCer)
• Lactosylceramide (LacCer)
• Ganglioside GM3
• Other

By Source:

• Synthetic
• Semi-synthetic
• Natural

By Application:

• Conventional Lipid-based Drug Delivery Systems (LBDDS)
• Self-Emulsifying Drug Delivery Systems (SEDDS)
• Self-Microemulsifying Drug Delivery Systems (SMEDDS)
• Liposomes
• Solid Lipid Nanoparticles
• Nanostructured Lipid Carriers
• Others

By Form:

• Liquid
• Semi-solid
• Solid

By End User:

• Pharmaceutical Companies
• Biopharmaceutical Companies
• Academics and Research Institutes
• Others

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs